TY  - RPRT
TI  - Transcutaneous delivery of disease specific PI3K/Akt/mTOR inhibitor based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies
AU  - keshari, R.
AU  - Bagale, R.
AU  - Rath, S.
AU  - De, A.
AU  - Banerjee, R.
AU  - Sen, S.
AU  - Srivastava, R.
PY  - 2024
DO  - 10.1101/2024.06.17.599287
UR  - https://www.biorxiv.org/content/10.1101/2024.06.17.599287v1
ID  - 10.1101/2024.06.17.599287
ER  -